NATtrol SARS-CoV-2 External Run Controls are formulated with purified, intact viral particles (Positive control) and human A549 cells (Negative control)….
Read More
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
Background: Fibroblast growth factor (FGF-23) concentration, a hormone that governs the phosphorus and the metabolism of vitamin D, increase as…
Read More
Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization study
The pathological excess of fibroblast growth factor 23 (FGF23) causes mineral disorders and bones. However, the causality of the FGF23…
Read More
Effect of HBO therapy on adipose-derived stem cells, fibroblasts and co-cultures: In vitro study of oxidative stress, angiogenic potential and production of pro-inflammatory growth factors in co-cultures1
Background: A key moderator of wound healing is oxygen. The healing of the wounds is a dynamic and carefully orchestrated…
Read More
Enhancing the developmental competence of prepubertal lamb oocytes by supplementing the in vitro maturation medium with sericin and the fibroblast growth factor 2 – leukemia inhibitory factor – Insulin-like growth factor 1 combination
The mediocre development of prepubilier animal oocytes is a major factor that prevents the application of technology, juvenile in vitro…
Read More
Safety and efficacy of basic fibroblast growth factors for deep second-degree burn patients
Introduction: Burning wounds are common afflictions; However, conservative wound care frequently lead to poor compliance with physical treatment and disability…
Read More
miR-188-3p Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Targeting Fibroblast Growth Factor 1 (FGF1)
Context As one of the crucial causes leading to cardiovascular disease, atherosclerosis (AS) develops in combination with the dysfunction of…
Read More
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
S1400D is a biomarker-driven therapeutic substudy Lung-MAP evaluate fibroblast growth factor (FGF) receptor (FGFR) inhibitor AZD4547 in patients with squamous…
Read More
Glucosamine impedes transforming growth factor β1-mediated corneal fibroblast differentiation by targeting Krüppel-like factor 4.
Transforming growth factor (TGF) family members play an important role in the regulation of the integrity of the cornea, and…
Read More
Fibroblast growth factor-2 and interleukin-4 synergistically induce eotaxin-1 expression in adipose tissue-derived stromal cells.
The relationship between eosinophils and adipose tissues involved in metabolic homeostasis. Eotaxin is a chemokine with potent effects on eosinophil…
Read More